Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

353O Efficacy and safety of ENZ-124 versus innovator cetuximab in combination with platinum-based chemotherapy in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN).

Autor: Dhamne, N.¹ (AUTHOR), Jain, M.² (AUTHOR), Nagarkar, R.³ (AUTHOR), Das Majumdar, S.K.K.⁴ (AUTHOR), Deshmukh, C.D.⁵ (AUTHOR), Dana, R.⁶ (AUTHOR), Ganesan, P.⁷ (AUTHOR), Chatterjee, K.⁸ (AUTHOR), Chatterjee, S.⁹ (AUTHOR), Prabhash, K.¹⁰ (AUTHOR), Sharma, A.¹¹ (AUTHOR), Mahobia, V.K.¹² (AUTHOR), Kumar, R.¹³ (AUTHOR), S.s., P.¹⁴ (AUTHOR), A, M.¹⁵ (AUTHOR), Chaitnya, P.K.¹⁶ (AUTHOR), Choudhary, V.G.¹⁷ (AUTHOR), Malhotra, H.¹⁸ (AUTHOR), Aagre, S.V.¹⁹ (AUTHOR), Maniar, V.²⁰ (AUTHOR)

Publikováno v: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1607-S1607. 1p.